Our primary exposure of interest was adherence to the first prescribed oral agent, measured from drug initiation date until the first elevated A1C result at least 3 months after the initiation date.

This article describes the trajectory of adherence patterns among users of sodium-glucose cotransporter 2 (SGLT2) inhibitors. The authors found that baseline factors were unable to predict the ...

Utilization of an Outpatient Integrated Infusion Suite to Decrease Length of Stay, Increase Revenue, and Improve Patient Experience for Elective Chemotherapy Admissions This retrospective cohort study ...

The chosen studies featured various methods to assess medication use initiation, implementation, and/or persistence in patients with chronic obstructive pulmonary disease (COPD). The researchers ...

Please provide your email address to receive an email when new articles are posted on . Women with breast cancer enrolled in Medicaid initiated adjuvant endocrine therapy a median 53 days after cancer ...

For all our advances in healthcare — more precise medications, greater access to care, smarter technology — one issue stubbornly persists: medication nonadherence. Nearly half of people with chronic ...

Medication nonadherence is not new, but it remains a persistent, complex problem. Adherence rates hover near 50%—roughly the same as two decades ago—as companies explore new ways to engage patients ...

Few patients with opioid toxicity receive opioid agonist therapy (OAT), data suggest. In a retrospective study that examined about 21,000 hospital visits related to opioid use disorder (OUD) in ...

Researchers explored the link between medication adherence and symptom distress in patients with breast cancer undergoing endocrine therapy.

Medication nonadherence in pulmonary arterial hypertension (PAH) significantly increases the risk of mortality and poor clinical outcomes.